150 related articles for article (PubMed ID: 24380501)
41. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
Datta SD; Koutsky LA; Ratelle S; Unger ER; Shlay J; McClain T; Weaver B; Kerndt P; Zenilman J; Hagensee M; Suhr CJ; Weinstock H
Ann Intern Med; 2008 Apr; 148(7):493-500. PubMed ID: 18378945
[TBL] [Abstract][Full Text] [Related]
42. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
43. Impact of an educational tool on young women's knowledge of cervical cancer screening recommendations.
Thiel de Bocanegra H; Dehlendorf C; Kuppermann M; Vangala SS; Moscicki AB
Cancer Causes Control; 2022 Jun; 33(6):813-821. PubMed ID: 35312891
[TBL] [Abstract][Full Text] [Related]
44. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.
Ferreccio C; Barriga MI; Lagos M; Ibáñez C; Poggi H; González F; Terrazas S; Katki HA; Núñez F; Cartagena J; Van De Wyngard V; Viñales D; Brañes J
Int J Cancer; 2013 Feb; 132(4):916-23. PubMed ID: 22684726
[TBL] [Abstract][Full Text] [Related]
45. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
46. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
47. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.
Mao C; Kulasingam SL; Whitham HK; Hawes SE; Lin J; Kiviat NB
J Womens Health (Larchmt); 2017 Jun; 26(6):609-615. PubMed ID: 28332888
[TBL] [Abstract][Full Text] [Related]
48. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
49. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
50. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
[TBL] [Abstract][Full Text] [Related]
51. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.
Ajenifuja OK; Ikeri NZ; Adeteye OV; Banjo AA
Pan Afr Med J; 2018; 30():110. PubMed ID: 30364362
[TBL] [Abstract][Full Text] [Related]
52. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
53. Organised screening for cervical cancer in France: a cost-effectiveness assessment.
Barré S; Massetti M; Leleu H; De Bels F
BMJ Open; 2017 Oct; 7(10):e014626. PubMed ID: 28988162
[TBL] [Abstract][Full Text] [Related]
54. Primary HPV testing recommendations of US providers, 2015.
Cooper CP; Saraiya M
Prev Med; 2017 Dec; 105():372-377. PubMed ID: 29056319
[TBL] [Abstract][Full Text] [Related]
55. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians.
de la Cruz MS; Young AP; Ruffin MT
J Am Board Fam Med; 2013; 26(6):720-7. PubMed ID: 24204068
[TBL] [Abstract][Full Text] [Related]
57. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
58. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
59. Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.
Castle PE; Silva VRS; Consolaro MEL; Kienen N; Bittencourt L; Pelloso SM; Partridge EE; Pierz A; Dartibale CB; Uchimura NS; Scarinci IC
Cancer Prev Res (Phila); 2019 Mar; 12(3):159-170. PubMed ID: 30651294
[TBL] [Abstract][Full Text] [Related]
60. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
